SCHEMBL17155484

SCHEMBL17155484

CCc1ccc(Cl)cc1-c1cccc(C(=O)NCCN(C)C)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKD3 O94806 1/20 0.48
PRKD1 Q15139 1/20 0.48
PRKD2 Q9BZL6 1/20 0.48
MAPK8 P45983 1/20 0.48
MAPK10 P53779 1/20 0.48
MAPK14 Q16539 1/20 0.48
MAP4K4 O95819 1/20 0.47
LMNA P02545 1/20 0.47
UTS2R Q9UKP6 4/20 0.47
HPGD P15428 1/20 0.47
KMT2A Q03164 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
KDR P35968 1/20 0.46
CAMK2D Q13557 2/20 0.46
TMEM97 Q5BJF2 1/20 0.46
SIGMAR1 Q99720 1/20 0.46
PDE1A P54750 1/20 0.46
PDE1B Q01064 1/20 0.46
PDE4D Q08499 1/20 0.46
PDE7A Q13946 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17154234 0.89 UTS2R (0.46) PRKD3PRKD1PRKD2MAPK8MAPK10
SCHEMBL17155168 0.86 CAMK2D (0.52) PRKD3PRKD1PRKD2MAPK8MAPK10
SCHEMBL13060646 0.79 FYN (0.52) PRKD3PRKD1PRKD2MAP4K4CAMK2D
SCHEMBL13060639 0.78 FYN (0.55) PRKD3PRKD1PRKD2MAP4K4KMT2A
SCHEMBL17066988 0.76 FYN (0.52) PRKD3PRKD1PRKD2MAP4K4CAMK2D
SCHEMBL1679539 0.76 PRKD3 (0.71) PRKD3PRKD1PRKD2MAP4K4KDR
SCHEMBL4293948 0.75 MAPK8 (0.47) PRKD3PRKD1PRKD2MAPK8MAPK10
SCHEMBL17154227 0.75 FYN (0.49) PRKD3PRKD1PRKD2MAPK8MAPK10
SCHEMBL12333454 0.75 USP2 (0.55) LMNAKMT2ASMN1; SMN2TMEM97SIGMAR1
SCHEMBL4199241 0.75 KDR (0.55) PRKD3PRKD1PRKD2MAPK8MAPK10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9388179-B2 N-substituted indazole sulfonamide compounds with selective activity in voltage-gated sodium channels MERCK SHARP & DOHME CORP. (US) 2016-07-12 US disclosed
US-20150284389-A1 N-SUBSTITUTED INDAZOLE SULFONAMIDE COMPOUNDS WITH SELECTIVE ACTIVITY IN VOLTAGE-GATED SODIUM CHANNELS MERCK SHARP & DOHME CORP. (US) 2015-10-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150284389-A1 N-SUBSTITUTED INDAZOLE SULFONAMIDE COMPOUNDS WITH SELECTIVE ACTIVITY IN VOLTAGE-GATED SODIUM CHANNELS SCN1B, SCN1A, SCN2B PRKD3 1755/4885PRKD1 2024/4885PRKD2 1850/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.